Castleark Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-88,190
Closed -$5.75M 350
2021
Q2
$5.75M Buy
+88,190
New +$5.58M 0.19% 130
2016
Q1
Sell
-143,352
Closed -$5.75M 390
2015
Q4
$5.75M Sell
143,352
-48,393
-25% -$2.05M 0.17% 144
2015
Q3
$9.31M Sell
191,745
-69,089
-26% -$3.28M 0.3% 91
2015
Q2
$11.6M Sell
260,834
-10,100
-4% -$388K 0.31% 100
2015
Q1
$8.67M Buy
270,934
+100,780
+59% +$3.25M 0.21% 148
2014
Q4
$5.34M Buy
+170,154
New +$4.12M 0.14% 163

Other funds holding INGN

Castleark Management's INGN Position: Q3 2021 in Review

Castleark Management sold out of Inogen (INGN) in Q3 2021, closing a stake of 88,190 shares — an estimated $5.75M sold.

Castleark Management first reported a position in INGN in Q4 2014 and held it in 6 quarters. The position peaked at $11.6M in Q2 2015. 170 funds tracked by Wall St. Rank hold INGN as of Q3 2021.

  • Castleark Management reported no remaining Inogen position as of Q3 2021 after selling out during the quarter.
  • Castleark Management sold 88,190 Inogen shares in Q3 2021, an estimated $5.75M.
  • Castleark Management first reported a position in Inogen in Q4 2014 and held it in 6 quarters.
  • Castleark Management's Inogen position peaked at $11.6M in Q2 2015.
  • 170 funds tracked by Wall St. Rank held Inogen as of Q3 2021.

Based on Castleark Management's 13F filing for Q3 2021, filed 12 Nov 2021.